2m 2m 2m 2m 2m 2m 2m
Axogen (AXGN)
NASDAQ
$40.98+$1.52 (+3.85%)
Price as of Jun 03, 2026 5:50 PM EDT- $2.1BMarket Cap
- 247.36%1-Year Change
- Medical DevicesIndustry
Axogen (AXGN)
$40.98+$1.52 (+3.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 225.2M +20.21% | 187.3M +17.81% | 159.0M +14.74% | 138.6M +8.81% | |
Cost of Revenue | 57.9M +27.54% | 45.4M +45.68% | 31.1M +28.95% | 24.1M +5.30% | |
Gross Profit | 167.4M +17.87% | 142.0M +11.03% | 127.9M +11.74% | 114.4M +9.59% | |
Sales and Marketing Expense | 97.7M +24.57% | 78.5M -8.83% | 86.1M +7.27% | 80.2M +9.41% | |
Research and Development Expense | -32.9M +18.43% | -27.8M -2.00% | -28.3M +4.33% | -27.2M +12.33% | |
Depreciation and Amortization Expense | 315,000 +17.98% | 267,000 -2.20% | 273,000 +3.02% | 265,000 +31.19% | |
Total Operating Expenses | 175.2M +20.61% | 145.3M -2.73% | 149.3M +3.60% | 144.1M +11.01% | |
Operating Profit | -7.8M +138.79% | -3.3M -84.68% | -21.5M -27.75% | -29.7M +16.88% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -756,000 -73.33% | -2.8M +354.33% | -624,000 -53.98% | |
Interest Income and Expense and Net | 0 +100.00% | -756,000 -73.33% | -2.8M +354.33% | -624,000 -53.98% | |
Total Nonoperating Income and Expense | -7.9M +17.63% | -6.7M +2,528.74% | -254,000 -133.47% | 759,000 +148.37% | |
Income before Taxes | -7.8M +138.79% | -3.3M -84.68% | -21.5M -27.75% | -29.7M +16.88% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -15.7M +57.60% | -10.0M -54.12% | -21.7M -24.98% | -28.9M +7.27% | |
Net Income from Continuing Operations Applicable to Common | -15.7M +57.60% | -10.0M -54.12% | -21.7M -24.98% | -28.9M +7.27% | |
Basic EPS and Net Income | -0.34 +47.83% | -0.23 -54.90% | -0.51 -26.09% | -0.69 +6.15% | |
Diluted EPS and Net Income | -0.34 +47.83% | -0.23 -54.90% | -0.51 -26.09% | -0.69 +6.15% | |
Basic Weighted Average Shares | 46.1M +4.05% | 44.3M +3.22% | 42.9M +1.89% | 42.1M +2.11% | |
Diluted Weighted Average Shares | 46.1M +4.05% | 44.3M +3.22% | 42.9M +1.89% | 42.1M +2.11% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.5M +29.01% | 27.6M -11.18% | 31.0M +102.98% | 15.3M -53.34% | |
Short-Term Investments | 6.0M +0.88% | 5.9M N/A | 0 -100.00% | 33.5M -34.73% | |
Cash and Cash Equivalents and Short-Term Investments | 41.5M +24.03% | 33.5M +7.92% | 31.0M -36.41% | 48.8M -41.98% | |
Total Current Assets | 120.4M +21.37% | 99.2M +12.74% | 88.0M -10.27% | 98.1M -22.81% | |
Accumulated Depreciation | 26.4M +32.74% | 19.9M +45.37% | 13.7M +33.03% | 10.3M +36.44% | |
Property and Plant and Equipment and Net | 81.8M -3.41% | 84.7M -4.58% | 88.7M +11.90% | 79.3M +26.10% | |
Total Long-Term Assets | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Assets | 221.7M +8.82% | 203.7M +3.51% | 196.8M +0.74% | 195.4M -6.07% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 23.6M -23.04% | 30.6M +0.59% | 30.4M +28.11% | 23.8M -2.22% | |
Total Long-Term Debt | 48.4M +1.88% | 47.5M +1.92% | 46.6M +1.95% | 45.7M +1.99% | |
Total Long-Term Liabilities | 141,000 +50.00% | 94,000 -99.81% | 49.6M -1.27% | 50.2M N/A | |
Total Liabilities | 92.8M -6.99% | 99.8M -1.33% | 101.2M +7.18% | 94.4M -1.14% | |
Retained Earnings | -307.0M +5.39% | -291.3M +3.54% | -281.3M +8.37% | -259.6M +12.55% | |
Total Stockholders Equity | 128.8M +24.00% | 103.9M +8.62% | 95.7M -5.28% | 101.0M -10.26% | |
Total Shares Outstanding | 47.2M +6.91% | 44.1M +2.38% | 43.1M +1.60% | 42.4M +1.70% | |
Cash Flow | |||||
Cash from Operating Activities | 812,000 -82.09% | 4.5M +179.34% | -5.7M -64.42% | -16.1M +19.85% | |
Capital Expenditures | 3.7M +20.77% | 3.1M -77.65% | 13.9M -30.91% | 20.1M -27.81% | |
Cash from Investing Activities | -5.3M -48.36% | -10.3M -153.48% | 19.3M +701.66% | -3.2M -86.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.5M +358.47% | 2.3M +17.20% | 2.0M +8.92% | 1.8M -91.23% | |
Financials Ratio | |||||
Gross Margin | 74.31% -1.95% | 75.79% -5.76% | 80.42% -2.61% | 82.58% +0.71% | |
Operating Margin | -3.49% +98.63% | -1.75% -87.00% | -13.50% -37.04% | -21.44% +7.42% | |
Return on Assets | -7.38% +48.39% | -4.98% -55.07% | -11.07% -22.84% | -14.35% +8.87% | |
Return on Equity | -13.49% +35.13% | -9.99% -54.79% | -22.08% -18.54% | -27.11% +18.40% | |
Revenue Growth | 20.21% +13.48% | 17.81% +20.85% | 14.74% +67.23% | 8.81% -34.26% | |
Current Ratio | 5.11 +57.72% | 3.24 +12.08% | 2.89 -29.96% | 4.13 -21.05% | |
Cash Ratio | 1.51 +67.64% | 0.90 -11.70% | 1.02 +58.43% | 0.64 -52.28% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow